Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults [Phase 3]
Phase 3 trial evaluating ombitasvir/paritaprevir/ritonavir with dasabuvir and ribavirin in treatment-naive and treatment-experienced adults …
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1) [Phase 3]
Phase 3 AGATE-1 evaluated the safety and efficacy of Ombitasvir/Paritaprevir/Ritonavir with Ribavirin in adults with genotype 4 chronic hepa…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus Infection [Phase 3]
A Phase 3 trial evaluating the safety and efficacy of the Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir regimen (with or without Ribavirin…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Adult-to-Adult Living Donor Liver Transplantation Study
This clinical trial update reports the completion of the Adult-to-Adult Living Donor Liver Transplantation study (NCT00096733), sponsored by…
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection [Phase 2]
Clinical trial update for HepNet Acute HCV IV using Ledipasvir/Sofosbuvir in acute genotype 1 HCV infection; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-28Clinical Trial Update: Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients [Phase 4]
A Phase 4 trial compared 12 weeks versus 24 weeks of extended treatment in chronic hepatitis C patients (genotypes 2/3); the study was termi…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Monitoring Liver Disease Progression in Hepatitis C/HIV Co-infected Patients With No-to-moderate Fibrosis, in Phnom Penh, Cambodia
A clinical trial assessing liver disease progression in Hepatitis C and HIV co-infected patients with no-to-moderate fibrosis in Phnom Penh …
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers
A clinical trial investigating detection of hepatitis C infection using the OraQuick test among healthcare workers; current status is unknow…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Study of SCY-635, Pegasys and Copegus in Hepatitis C [Phase 2]
Phase 2 trial of SCY-635 in combination with Pegasys and Copegus for Hepatitis C has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Integrating HIV and Hepatitis C Screening in an Urban Emergency Department [NA]
Clinical trial evaluating integrating HIV and Hepatitis C screening in an urban emergency department. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving Sofosbuvir and Daclatasvir
This Clinical Trial Update discusses a study evaluating the early occurrence of hepatocellular carcinoma in Egyptian patients infected with …
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b [Phase 3]
Open-label Phase 3 study evaluating the efficacy and safety of the elbasvir/grazoprevir fixed-dose combination in adults with chronic hepati…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Intravenous Interferon During Liver Transplant [NA]
A completed clinical trial investigating intravenous interferon during liver transplant with Hepatitis C and cirrhosis as conditions; result…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection [Phase 1]
This entry reports the completion of a Phase I trial evaluating the safety, tolerability, and immunogenicity of VGX-6150 as second-line ther…
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Hepatitis C Antiviral Resistance in African-Americans [Phase 3]
A Phase 3 clinical trial update on antiviral resistance in hepatitis C among African-Americans; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in Brazil [Phase 3]
A Phase 3 Brazilian trial evaluated the efficacy and safety of three experimental drugs in adults with chronic hepatitis C infection, includ…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT) [Phase 4]
A Phase 4 randomized trial evaluated 12-week regimens of sofosbuvir plus daclatasvir or sofosbuvir plus simeprevir in non-cirrhotic adults w…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Use-Results Surveillance Study of Sovaldi® Plus Rebetol® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection
A completed use-results surveillance study evaluating the combination of Sovaldi (sofosbuvir) plus Rebetol (ribavirin) in Japanese patients …
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study [Phase 2]
Phase 2 trial update evaluating sofosbuvir/velpatasvir with ribavirin in adults with chronic hepatitis C who previously participated in a Gi…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt [Phase 3]
Phase 3 trial update on coadministration of ABT-450/Ritonavir/ABT-267 with Ribavirin in adults with genotype 4 hepatitis C in Egypt; study c…
-
CLINICAL_TRIALS trial_result · 2017-07-25Clinical Trial Update: Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection [Phase 4]
Phase 4 trial update assessing changes in liver steatosis after switching HIV/HCV coinfected patients to raltegravir; study completed.
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults [Phase 1]
Phase 1 study to assess how omeprazole and ritonavir influence the pharmacokinetics of GSK2336805 in healthy adults; the study was completed…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805 [Phase 1]
This update notes the completion of a Phase 1 cross-over trial evaluating the cardiovascular effects of the hepatitis C investigational drug…
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: SR-BI and Antiviral Treatment Response in HCV
A clinical trial update examining the relationship between the SR-BI receptor and antiviral treatment response in chronic hepatitis C, spons…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia [Phase 4]
Phase 4 trial update on community-based treatment of chronic hepatitis C monoinfection and HIV coinfection in DC; study completed with resul…